FAQ

ESTROGENS,VAGINAL

Known as: Vaginal estrogen, estrogen vaginal, vaginal estrogens 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2016
012320142016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Effect of vaginal estrogen on pessary use
Many providers recommend concurrent estrogen therapy with pessary use to limit complications; however, limited data exist to… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2016
2016
Vaginal estrogen use and effects on quality of life and urogenital morbidity in postmenopausal women after publication of the Women's Health Initiative in New York City.
OBJECTIVE In the years after the 2002 publication of results from the Women's Health Initiative study, there has been a… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2016
Review
2016
Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy
Atrophic vaginitis represents a major barrier to compliance with aromatase inhibitor (AI) therapy in breast cancer (BC) survivors… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2015
2015
Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?
OBJECTIVE Pelvic organ prolapse is often co-existant with atrophy of the genital tract in older women who tend to prefer vaginal… (More)
Is this relevant?
Review
2015
Review
2015
[Use of local estrogenotherapy in urology and pelviperineology: A systematic review].
OBJECTIVE To conduct a literature review of the efficiency of vaginal local estrogenotherapy (LE) on genitourinary disorders… (More)
Is this relevant?
2014
2014
From systemic hormone therapy to vaginal estrogen - a nationwide register study in Finland, 2003-2012.
OBJECTIVES To assess the patterns of use of reimbursed systemic hormone therapy (HT) and vaginal estrogen preparations among… (More)
  • table 1
Is this relevant?